X. Chu

Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation‐negative non‐small cell lung cancer

Abstract Brain metastasis (BM) is a common complication of advanced non‐small cell lung cancer (NSCLC). Although immune checkpoint inhibitors (ICIs) have demonstrated efficacy in treating NSCLC‐BM, their clinical benefits are often limited. The combination of radiotherapy (RT) and ICIs has emerged as a promising strate...